Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-06-04Clinical Trial Update: Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer - Protocol 2 [Phase 2]
Phase 2 clinical trial update evaluating fairly brief androgen suppression combined with stereotactic radiotherapy for high-risk prostate ca…
-
CLINICAL_TRIALS trial_result · 2021-05-28Clinical Trial Update: A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued. [Phase 2]
A Phase 2 rollover study of tremelimumab for patients who had received it in other protocols, to provide continued access until it becomes c…
-
FDA approval · 2021-05-26FDA Approved: PYLARIFY — Original Application (Progenics Pharmaceuticals, Inc.)
FDA approves PYLARIFY (piflufolastat F-18) as an original NDA for PET imaging to detect suspected recurrent prostate cancer in adults.
-
FDA approval · 2021-05-24FDA Approved: XTANDI — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for XTANDI (enzalutamide) from Astellas Pharma US, Inc., marking an update to the drug's labeling.
-
FDA approval · 2021-05-21FDA Approved: AXUMIN — Supplemental Application (Blue Earth Diagnostics)
FDA approved a supplemental application for AXUMIN (fluciclovine F-18) submitted by Blue Earth Diagnostics, resulting in updated labeling th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-05-21Clinical Trial Update: Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer [Phase 4]
Phase 4 study evaluating enzalutamide plus flutamide in castration-resistant prostate cancer has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2021-05-19Clinical Trial Update: A Feasibility Study Followed By A Randomized Phase II Study Of Yoga For Radiation Therapy Side Effects In Prostate Cancer
A feasibility study followed by a randomized Phase II trial evaluating yoga for radiation therapy side effects in prostate cancer has been c…
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: 68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating 68Ga-RM2 PET/CT imaging of GRPr expression in prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer [Phase 2]
Phase 2 trial update for abiraterone acetate in metastatic hormone-resistant prostate cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-05-12Clinical Trial Update: Observation or Radical Treatment in Patients With Prostate Cancer [NA]
A terminated clinical trial evaluating observation versus radical treatment strategies in patients with prostate cancer, with posted results…
-
CLINICAL_TRIALS trial_result · 2021-05-12Clinical Trial Update: Use of Indocyanine Green During Pelvic Lymph Node Dissection in Prostate Cancer. [Phase 4]
Phase 4 clinical trial update evaluating the use of Indocyanine Green during pelvic lymph node dissection in prostate cancer.
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer [Phase 2]
Phase 2 trial update of enzalutamide plus LY3023414 in metastatic prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancer [Phase 1]
A Phase 1 trial comparing capsule and liquid formulations of enzalutamide after a single dose under fasting conditions in prostate cancer wa…
-
CLINICAL_TRIALS trial_result · 2021-05-06Clinical Trial Update: Nutrition and Prostate Cancer [Phase 3]
Phase 3 clinical trial about nutrition and prostate cancer was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-06Clinical Trial Update: MBM-02 (Tempol) for the Treatment of Biochemical Recurrent Prostate Cancer [Phase 2]
Phase 2 clinical trial update for MBM-02 (Tempol) in biochemical recurrent prostate cancer is in progress, with unknown current status.
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: GTI-2040, Docetaxel, and Prednisone in Treating Patients With Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating GTI-2040 with docetaxel and prednisone in prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Shorter Duration Radiotherapy to Treat Prostate Cancer After Removal of the Prostate [Phase 1, Phase 2]
A completed clinical trial evaluating shorter-duration radiotherapy for prostate cancer following prostate removal, spanning Phase 1 and Pha…
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: A Phase II Study Evaluating the Efficacy of Enzalutamide and the Role of ARv7 in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients With Visceral Disease. [Phase 2]
A Phase II study evaluating enzalutamide and ARv7 in metastatic castration-resistant prostate cancer with visceral metastases has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: Study Of Tasquinimod In Asian Chemo-Naïve Patients With Metastatic Castrate-Resistant Prostate Cancer [Phase 3]
Phase 3 trial of tasquinimod in Asian chemo-naïve patients with metastatic castration-resistant prostate cancer was terminated; results post…
-
CLINICAL_TRIALS trial_result · 2021-04-21Clinical Trial Update: Urology San Antonio MRI/MicroUS Comparison [NA]
Clinical trial update for a prostate cancer imaging study comparing MRI and MicroUS completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: A Trial Assessing Post-Operative Use of ProSpare, a Rectal Obturator in Prostate Cancer Radiotherapy [Phase 2]
Phase 2 trial update evaluating Post-Operative use of ProSpare, a rectal obturator, in prostate cancer radiotherapy.
-
CLINICAL_TRIALS trial_result · 2021-04-13Clinical Trial Update: ADT Exercise Trial and Economic Analysis [Phase 3]
Phase 3 clinical trial update on exercise intervention for prostate cancer with economic analysis completion.
-
CLINICAL_TRIALS trial_result · 2021-04-13Clinical Trial Update: An Exercise Trial and Economic Analysis in Men With Prostate Cancer [Phase 2]
A Phase 2 clinical trial update examining an exercise intervention and economic analysis in men with prostate cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate Cancer [Phase 2]
Phase 2 trial evaluating ZK-Epo in combination with prednisone for metastatic androgen-independent prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery [Phase 2]
Phase II trial exploring a multimodal approach (gene therapy & androgen deprivation therapy, radiotherapy, and surgery) for high-risk prosta…